Acuerdo de riesgo compartido en el tratamiento con certolizumab pegol en pacientes adultos con psoriasis moderada-grave: datos en PRÁCTICA CLÍNICA real

Estimation of avoidable costs in the care process of axial spondyloarthritis and psoriatic arthritis, based on possible improvements of inefficiencies in the current care process.

Authors: Andrés Navarro Ruiz; Fernando Toledo; Eva Vilarrasa; Francisco Rodríguez Lucena; Francisco Javier Mataix Díaz; Inés Poveda Montoyo; Jaime E. Poquet Jornet; Joaquin Borras Blasco; Luca Schneller Pavelescu-Apetrei; Mª Angeles Cía Barrio; Mª Antonia Mangues Bafalluy; Rafael Ubeda Bonete; Rebeca Alcalá García; Sergio Santos Alarcón; Susana Aceituno Mata; Maria Soler Martinez

Year: 2022

Congress: Jornadas de Economía de la Salud

Download PDF

Subscribe to Outcomes´10

Name *

E-mail *

Todos los campos marcados con un * son obligatorios

Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. Data will be retained for the time necessary to fulfill its purpose and derived responsibilities by current regulations and the deadlines in the applicable regulations on archives and documentation. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy

I have read and accepted the privacy policy